Hepatitis B surface antigen (HBsAg) prevalence (%) in Laos
Laos: Hepatitis B surface antigen (HBsAg) prevalence was 0.6% in 2024. ▼ Falling
Latest (2024)
0.6%
Change on year
unchanged
World rank
51st
of 194 countries
All-time high
1.8%
in 2015
All-time low
0.6%
in 2023
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Laos, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, hepatitis b surface antigen (hbsag) prevalence in Laos stood at 0.6%. That is the lowest value across all 10 years on record.
That represents a change of down 66.7% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Laos peaked at 1.8% in 2015 and was at its lowest, 0.6%, in 2023.
That places Laos 51st out of 194 countries with data for 2024, putting it in the middle of the range.
Hepatitis B surface antigen (HBsAg) prevalence in Laos, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.8% | — |
| 2016 | 1.5% | -16.7% |
| 2017 | 1.3% | -13.3% |
| 2018 | 1.1% | -15.4% |
| 2019 | 0.8% | -27.3% |
| 2020 | 0.8% | +0.0% |
| 2021 | 0.7% | -12.5% |
| 2022 | 0.7% | +0.0% |
| 2023 | 0.6% | -14.3% |
| 2024 | 0.6% | +0.0% |
Laos compared with similar countries
- Laos's 0.6% is above the median for lower middle income countries, which is 0.6%, 1.0× the median. (47 countries reporting)
- Laos's 0.6% is above the median for East Asia & Pacific, which is 0.6%, 1.0× the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.3% | 0.8% | 1.8% | 5 |
| 2020s | 0.7% | 0.6% | 0.8% | 5 |
Countries ranked near Laos
- 51 Tonga 0.6% compare
- 51 Cote d'Ivoire 0.6% compare
- 51 Ethiopia 0.6% compare
- 51 Micronesia (country) 0.6% compare
- 51 Madagascar 0.6% compare
- 51 Nauru 0.6% compare
- 51 Palau 0.6% compare
More health data for Laos
- Un projection of annual infant deaths, annual growth rate -2.76 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5667 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,260 deaths per 1,000 people (2090)
- Number of infants who die before age 1 317 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 15 (2025)
- Population ages 00-04, female, annual growth rate -0.5161 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0489 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5055 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Laos?
- Hepatitis b surface antigen (hbsag) prevalence in Laos was 0.6% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Laos?
- The highest recorded value was 1.8% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Laos?
- The lowest recorded value was 0.6% in 2023.
- How does Laos rank for hepatitis b surface antigen (hbsag) prevalence?
- Laos ranks 51st out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Laos?
- Over the last ten years it is down 66.7%. The long-run trend across the full record is falling.
- Where does this Laos data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).